The US Food and Drug Administration has also started to recognize the potential of these drugs: in 2018, they designated certain psychedelic treatments with a “breakthrough therapy” status, which means that it has therapeutic potential. Several renowned medical schools and hospitals around the United States have also opened psychedelic medicine departments which have been entirely devoted to studying the impact of psilocybin and LSD.
Except the science keeps saying it isn't simple at all. The THC percentage is a…
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…